Clinical Chemistry and Laboratory Medicine (CCLM)
Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
Editor-in-Chief: Plebani, Mario
Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R.
IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition
SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238
First trimester biochemistry at different maternal ages
1Department of Clinical Chemistry, School of Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland
2Eastern Finland Laboratory Centre, Kuopio, Finland
3Department of Obstetrics and Gynaecology, Oulu University Hospital, Oulu, Finland
4Central Ostrobothnia Hospital District, Kokkola, Finland
5Laboratory, Seinäjoki Central Hospital, Seinäjoki, Finland
6Department of Obstetrics and Gynaecology, Kuopio University Hospital, Kuopio, Finland
7Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland
8HUSLAB, Women’s Clinic Laboratory, Helsinki Central University Hospital, Helsinki, Finland
9Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland
Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 50, Issue 3, Pages 549–555, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/cclm.2011.785, November 2011
- Published Online:
Background: The performance of first trimester biochemical screening was compared at different pregnancy weeks and maternal ages during 2002–2008 in a screened population of 76,949 women.
Methods: The detection rates, as well as the median multiples of a median (MOMs) of free β-human chorionic gonadotropin (free β-hCG) and pregnancy-associated plasma protein-A (PAPP-A), were compared between completed gestational weeks 8–13 and between different maternal ages separated into 5-year groupings.
Results: The number of singleton Down syndrome pregnancies was 221. The median age of the screened women was 30 years and the proportion of women aged ≥35 years 16.9%. The median age of the women with a Down syndrome pregnancy was 37 years. In women aged <35 years, the biochemical markers provided a detection rate of only 38.6%, whereas in women aged ≥35 years, the biochemical markers detected 82.7% of cases (p<0.01).
Conclusions: Biochemical screening works best amongst women aged ≥35 years. For younger mothers aged <35 years, combined screening should be the method of choice.